The session was co-led by Louise Perrault, Co-Founder and President of IMAC, and Nicole Tunstall, Vice President of IMAC, bringing together decades of combined expertise in global market access consulting and regulatory strategy. Drawing on IMAC’s extensive experience, they provided invaluable insights into key strategies for optimizing SmPCs ahead of the JCA process.
In this Masterclass, Louise Perrault, Founder and CEO of International Market Access Consulting (IMAC) and A-TANGO consortium member, gives an in-depth Masterclass lecture on the importance of a solid MarketAccess strategy for any novel therapy, healthcare product, or medical service, how to access the healthcare market, and how to receive reimbursement in healthcare. The public Masterclass was held virtually on the 27th of March 2024 and recorded as part of the project's early-career scientists (ECS) training programme.